Extract
Asia has large country-to-country variations in COPD prevalence and mortality. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report covers many aspects of COPD, from causes and risk factors, to diagnosis, pharmacological and non-pharmacological treatment, and exacerbations [1]. We would like to make some comments on the relevance of the GOLD 2023 executive summary in Asia.
Abstract
GOLD 2023 executive summary: comments from Asia's perspective https://bit.ly/3zSvM9r
Footnotes
Conflict of interest: The authors have no conflict of interest to declare for this manuscript.
- Received April 1, 2023.
- Accepted April 3, 2023.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org
Vol 61 Issue 6
Table of Contents
GOLD 2023 executive summary: comments from Asia's perspective
